An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without Continuous Renal Replacement Therapy.
Latest Information Update: 23 Sep 2019
At a glance
- Drugs Ceftolozane/tazobactam (Primary)
- Indications Gram-negative infections
- Focus Pharmacokinetics
- Acronyms CT-PK
- 17 Aug 2019 Status changed from recruiting to completed.
- 29 Jul 2019 Results evaluating population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal impairment and assess adequacy of recommended dosing regimenspublished in the Antimicrobial Agents and Chemotherapy
- 27 Aug 2018 Status changed from not yet recruiting to recruiting.